Presentation TCT 2016 Stent Design and Comprehensive Data Review: Xience Cobalt Chromium Fluoropolymer-Based Everolimus-Eluting Stents Presenter: Dean J. Kereiakes, Pieter C. Smits, Tullio Palmerini October 30, 2016
Presentation TCT 2016 Overview of the Clinical Trials for Atherectomy Presenter: Schuyler Jones, Misti Malone, Brad Martinsen, PhD October 30, 2016
Presentation TCT 2016 Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others) Presenter: Felix Mahfoud, Michael A. Weber October 30, 2016
Presentation TCT 2016 Quality and Compliance in Research: The Crucial First Step Presenter: David A. Cox, Thomas D. Stuckey, Kate Dalton October 30, 2016
Presentation TCT 2016 Evolution of the Nurse/Tech Role in the Cath Lab Presenter: Regina Deible, Mary K. Egan October 30, 2016
Presentation TCT 2016 Overview of the Clinical Trials for Drug-Coated Balloons Presenter: Schuyler Jones, Misti Malone, George Papandreou October 30, 2016
Presentation TCT 2016 Building a Successful Clinical Research Enterprise at Your Hospital: Integrating Clinical Work Flow and Research Presenter: David A. Cox, Thomas D. Stuckey, Tamim Nazif October 30, 2016
Presentation TCT 2016 Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) Presenter: Horst Sievert October 30, 2016
Presentation TCT 2016 TAVR in Patients With Poor Femoral Access Presenter: Neal S. Kleiman, Patrick T. O'Gara, Richard Smalling October 30, 2016
Presentation TCT 2016 Severe AS and Extreme Co-morbidities (Futile Patient?) Presenter: Neal S. Kleiman, Patrick T. O'Gara, Suzanne V. Arnold October 30, 2016
Presentation TCT 2016 LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk Presenter: David W.M. Muller, Jonathan M. Hill, Philip M. Urban October 30, 2016
News Conference News TCT 2016 LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years Yael L. Maxwell October 30, 2016
Presentation TCT 2016 Management of Failing Aortic Bioprosthesis Presenter: Neal S. Kleiman, Patrick T. O'Gara, Danny Dvir October 30, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
Presentation TCT 2016 ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Presenter: David W.M. Muller, Jonathan M. Hill, Patrick W. Serruys October 30, 2016
Presentation TCT 2016 TAVR in Patients With Atrial Fibrillation Presenter: Neal S. Kleiman, Patrick T. O'Gara, Fabian Nietlispach October 30, 2016
Presentation TCT 2016 ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Presenter: David W.M. Muller, Jonathan M. Hill, Runlin Gao October 30, 2016
Presentation TCT 2016 Personalized Medicine Where Are We in 2016? Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy October 30, 2016
Presentation TCT 2016 Anti-inflammatory Therapies for Atherosclerosis Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif October 30, 2016
Presentation TCT 2016 Heart Failure Advances (Ivabradine, ARNI, and More) Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy October 30, 2016